Consultant; Honorary Professor
Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK
Catanzaro, Calabria, Italy
Molica, MD, is a consultant in Haematology department at Castle Hill Hospital, Hull (UK) and Honorary Professor of Hull York University.
Member of the American Society Clinical Oncology (ASCO), American Society Hematology (ASH), European Society Hematology, he has been actively involved in the GIMEMA (Gruppo Italiano Malattie Ematologiche Adulto) lymphoproliferative working group from 2010 to 2021.
His current research focuses on investigating the impact of novel laboratory parameters useful for assessing the prognosis of CLL and studying the role of novel agents in such a disease.
He has published 266 peer-reviewed papers primarily in the field of CLL and CLL-related disorders.
He is a member of the editorial board of Leukemia and Lymphoma, Cancers, BMC Medicine, ISRN Hematology, and International Journal Haematological Oncology.
He currently serves as a referee for several hematology-oncology journals such as Blood, Haematologica, Leukemia Research, Leukemia and Lymphoma, European Journal Haematology, Cancer, Lancet Oncology, Lancet Haematology, British Journal Haematology, Leukemia, American Journal Hematology.
Saturday, October 7, 2023
3:50 PM – 4:00 PM EDT
